Aducanumab: A Deep Dive into BIIB037 and its Impact This compound, originally known as BIIB037, constitutes a complex effort to address mild Alzheimer's condition. Designed by Biogen, the treatment works by targeting https://www.targetmol.com/compound/aducanumab